Delivery Order SPE2DB25D3404-SPE2DB25FUPJN
- Not listed
- The Defense Logistics Agency awarded a $2,174.46 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4562069577 units of HYPERRAB 300 UNIT/ML vials. The contract has a period of performance from September 6 through September 27, 2023. Amerisourcebergen Drug Corporation will fulfill the order from its facility located in Conshohocken, Pennsylvania. As a major supplier to the Department of Defense, Amerisourcebergen will deliver this pharmaceutical product in...
- The Defense Logistics Agency awarded a delivery order valued at $8,895.79 to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/ML Vial 5ML, a rabies immunoglobulin product used for post-exposure prophylaxis. This non-competed, firm fixed-price delivery order has a completion date of August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a $1,812 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical to supply 300 units of HYPERRAB 300 UNIT/ML vials. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The delivery order has a period of performance from September 6, 2023 through September 27, 2023. No subcontractors or set aside designations were...
- The Defense Logistics Agency Troop Support Medical awarded a $1,087.23 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561659486 units of HYPERRAB 300 UNIT/ML vials to be delivered to their Conshohocken, Pennsylvania facility by August 22, 2023. As the prime contractor, Amerisourcebergen Drug Corporation will fulfill the contract requirements from their Corporate Office Division location. The Defense Logistics Agency supports Department of Defense health care...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,659.62 firm fixed-price delivery order is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract has a completion date of January 3, 2025 and was awarded on December 11, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical distributor AmerisourceBergen Corporation. The $2,249.12 firm fixed price order is for the supply of HYPERRAB 300 UNIT/ML VIAL 3ML, a pharmaceutical product. No set-aside designation was used. The order has a completion date of February 13, 2024 and was awarded on January 23, 2024. AmerisourceBergen Drug Corp has received numerous prior federal contract...
- This is a $7,513.40 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,259 units of the pharmaceutical product HYPERRAB 300 UNIT/ML VIAL 5ML. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., will provide these critical medical supplies to support government healthcare programs. The contract has an ultimate completion date of August 16,...
- The Defense Logistics Agency awarded a $7,248.20 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 300 unit/ml vials of HYPERRAB. As the prime contractor, Amerisourcebergen will deliver the pharmaceutical products from its Conshohocken, Pennsylvania facility by July 26th to support the Defense Logistics Agency's medical supply needs. No subcontractors or set aside designations were indicated. The delivery order was issued against an existing DLA contract vehicle to...
- This is a $7,163.24 Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of HYPERRAB 300 UNIT/ML VIAL 5ML, a pharmaceutical product. The contract has an ultimate completion date of July 22, 2025 and was awarded on June 30, 2025. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is a firm fixed price delivery order for the supply of a specialty pharmaceutical product, HYPERRAB 300 UNIT/ML VIALML, with a potential value of $4,466.28 and a completion date of February 22, 2024. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, through its...
- SPE2DB25D3404Indefinite Delivery Contract
- SPE2DB25D3404-SPE2DB25FUPJNDelivery Order
The Defense Logistics Agency awarded a $1,732.55 delivery order to AmerisourceBergen Drug Corp for HYPERRAB 300 Unit/mL vials, with an ultimate completion date of August 11, 2025. This firm fixed-price contract represents a non-competitive, non-set-aside delivery order issued under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania, which serves as AmerisourceBergen's corporate headquarters and primary distribution hub for federal pharmaceutical procurement. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor specializing in medical supplies for military and veteran healthcare systems. Through its comprehensive DLA contract vehicle, the company supplies an extensive portfolio of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This delivery order for HYPERRAB (rabies immunoglobulin) supports the Defense Health Agency and other government healthcare systems' requirements for critical biologics and emergency medical countermeasures. The contract demonstrates AmerisourceBergen's ongoing role as a key supplier within the federal medical supply chain serving defense healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 7/21/25 |